Project Grant K08GM157557

Award Date 2/1/25
Completion Date 1/31/30
Dollars Obligated $190K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The federal Project Grant award R01AG086692 was provided by the National Institute on Aging (NIA) under the Aging Research grant program (CFDA 93.866) to Brandeis University. The $331,187 award will fund a 4-year study to understand the role of retrotransposon activity in aging and age-related phenotypes using the Drosophila model system. The goals of the project are to characterize a Drosophila system to determine whether transposon activity is a cause or effect of the aging process. This...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $393,750.00 to the University of California, Los Angeles (UCLA) to conduct research exploring the fundamental cellular mechanisms driving cellular senescence in macrophages. The overarching goal is to gain a deeper understanding of the cellular and molecular mechanisms underlying senescent macrophage biology,...
This federal Project Grant award, in the amount of $422,419, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of California, Los Angeles (UCLA) from December 15, 2024 to November 30, 2026. The award aims to unravel the molecular mechanisms underlying cellular rejuvenation through partial reprogramming using the OSKM transcription factors. Key objectives include mapping changes in the transcriptome, chromatin landscape, transcription factor binding,...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $449,625 to Trustees of Boston University to explore the role of circular RNAs in aging-related sepsis and organ damage. The research aims to determine the function and mechanisms of an aging-induced circular RNA, circ20033, in promoting pro-inflammatory activation of macrophages and lung inflammation after bacterial infections, particularly in older adults. The two-year project will...
This federal Project Grant award, with a total funding amount of $336,070.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, effective September 1, 2024, supports research conducted by Rutgers, The State University of New Jersey, to define and manipulate the gene regulatory networks that dictate the transition through senescence states. The research program aims to generate...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $408,600.00 to Trustees of Tufts College, doing business as Tufts University School of Medicine, to conduct research on the role of cytosolic DNA sensing in regulating tissue-resident macrophage function and organismal longevity. The key objectives of this research project are to: 1) Ascertain the role of endogenous retroelements in shaping tissue-resident macrophage survival and...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $651,793 to the University of California, San Diego (UCSD) to conduct research on translation fidelity in hematopoietic stem cell aging and longevity. The goal is to determine if young adult hematopoietic stem cells have elevated translation fidelity compared to older stem cells, and if enhancing translation fidelity can improve stem cell fitness and extend healthspan and lifespan. The...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,414,024 to The University of Texas Health Science Center at San Antonio to investigate the role of paracrine growth factor signaling in thymus function and age-associated dysfunction. The project aims to leverage existing genetic models and advanced imaging analysis to independently manipulate FGF21, mTOR, and autophagy pathways to understand their regulatory relationships and effects...
This Project Grant award of $400,000 was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to The Trustees of the University of Pennsylvania. The award will fund research to develop computational methods for measuring intrinsic biological noise in single-cell sequencing data across levels of chromatin accessibility, gene expression, and transcript splicing. The research aims to investigate the relationship between epigenetic, transcriptional, and splicing noise and...

This federal Project Grant award, totaling $190,278, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research to investigate the role of transposable elements, which are mobile genetic sequences, in sepsis-induced immune aging. The 5-year project aims to 1) examine the dynamics of transposable element de-repression as a function of age and sepsis, 2) use machine learning to quantify immune aging and identify transposable elements associated with immune aging or ICU outcomes, and 3) conduct genetic studies to determine if mutations, such as in the AGO2 gene, lead to transposable element de-repression. The research will be conducted by the Regents of the University of California, San Francisco, a leading academic medical center and research institution, with the goal of shedding light on genomic mechanisms underlying sepsis progression and potentially informing the development of novel, personalized therapies.

Generated 7/8/25, 1:54 PM